Procedural Sedation Withdrawn Phase 2 Trials for Midazolam (DB00683)

IndicationStatusPhase
DBCOND0034835 (Procedural Sedation)Withdrawn2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01402596Evaluation of Pediatric Procedural Sedation With Rectal Chloral Hydrate or Intranasal MidazolamDiagnostic